Federal Trade Commission Non-Compete Crackdown Shifts to Targeted Enforcement
Explore the FTC’s shift from a broad non-compete ban to targeted enforcement in 2025, its impact on businesses and workers, and evolving state and federal regulations.
Category: Healthcare
FDA, HIPAA & AI Rules: Oct 4, 2025 Compliance News You Need to Know
Stay ahead with today’s top compliance headlines in Life Sciences and Healthcare. From FDA’s cybersecurity guidance to HIPAA crackdowns and EMA updates — here’s what GRC professionals need to know today, October 4, 2025.
FDA drug promotion rules spotlight compounded meds in Hims & Hers Super Bowl ad controversy
This article unpacks the regulatory framework implicated by the Hims & Hers’ Super Bowl advertisement, explores the implications for the company and the broader pharmaceutical and telehealth industries, and discusses how evolving enforcement trends may shape future drug promotion practices.
FDA Mental Health Chatbot Rules Tighten Amid Rising AI Risks and Hype
The FDA’s announcement, published in the Federal Register, highlights the “novel risks” posed by devices having Mental Health Chatbots and signals a shift toward more stringent oversight to ensure safety and efficacy. This article explores the implications of these regulatory developments, the evolving landscape, and what it means for companies and users alike.
Stark Law & the Anti-Kickback Statute (AKS) in 2025: The Compliance Balancing Act
Navigate Stark Law and Anti-Kickback Statute compliance in 2025. Stay informed, implement strategies, and ensure ethical practices in your medical facility.
CMS Rescinds 2022 EMTALA Guidance: What Hospitals Must Know Now
The CMS has rescinded its 2022 EMTALA guidance, creating confusion for hospitals on abortion care amid legal risks. Learn how to navigate these changes effectively.